Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 8/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29385429 | 1.00 | SERPINE1 (0.49) | SERPINE1NPC1RAB9APOLBAPEX1 | |
| SCHEMBL18224153 | 0.96 | NPC1 (0.50) | NPC1RAB9APOLBAPEX1HTT | |
| SCHEMBL15224330 | 0.95 | NPC1 (0.46) | SERPINE1NPC1RAB9APOLBAPEX1 | |
| SCHEMBL30234496 | 0.91 | POLB (0.52) | SERPINE1NPC1RAB9APOLBAPEX1 | |
| SCHEMBL93331 | 0.91 | POLB (0.52) | SERPINE1NPC1RAB9APOLBAPEX1 | |
| SCHEMBL8735904 | 0.91 | NPC1 (0.60) | NPC1RAB9APOLBAPEX1HTT | |
| SCHEMBL93256 | 0.90 | HPGD (0.56) | NPC1RAB9APOLBAPEX1HTT | |
| SCHEMBL15329842 | 0.88 | POLB (0.52) | NPC1RAB9APOLBAPEX1HTT | |
| SCHEMBL22899541 | 0.88 | POLB (0.47) | SERPINE1POLBAPEX1HTTTDP1 | |
| SCHEMBL22899522 | 0.87 | POLB (0.54) | POLBAPEX1HTTTDP1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528965-B2 | Active energy curable resin composition, hard coat laminated film, and film for application to glass | RIKEN TECHNOS CORPORATION (JP) | 2026-01-20 | — | — | US | disclosed |
| US-12429722-B2 | Laminated glass | AGC Inc. (JP) | 2025-09-30 | — | — | US | disclosed |
| EP-3632943-B1 | ACTIVE ENERGY CURABLE RESIN COMPOSITION, HARD COAT LAMINATED FILM, AND FILM FOR APPLICATION TO GLASS | RIKEN TECHNOS CORP (JP) | 2024-10-16 | — | — | EP | disclosed |
| WO-2024057723-A1 | PHOTOCURABLE COATING COMPOSITION AND COATED ARTICLE | 信越化学工業株式会社 | 2024-03-21 | — | — | WO | disclosed |
| US-11899317-B2 | Laminated glass, and method for manufacturing laminated glass | AGC Inc. (JP) | 2024-02-13 | — | — | US | disclosed |
| US-20230176426-A1 | LAMINATED GLASS, AND METHOD FOR MANUFACTURING LAMINATED GLASS | AGC Inc. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230168530-A1 | LAMINATED GLASS | AGC Inc. (JP) | 2023-06-01 | — | — | US | disclosed |
| EP-4019561-A1 | ACTIVE ENERGY CURABLE RESIN COMPOSITION, HARD COAT LAMINATED FILM, AND FILM FOR APPLICATION TO GLASS | Riken Technos Corporation (JP) | 2022-06-29 | — | — | EP | disclosed |
| EP-2873704-B1 | Refinish coating system and repairing method for automotive resin glazing | SHINETSU CHEMICAL CO (JP) | 2022-03-23 | — | — | EP | disclosed |
| US-11248141-B2 | Active energy curable resin composition, hard coat laminated film, and film for application to glass | RIKEN TECHNOS CORPORATION | 2022-02-15 | — | — | US | disclosed |
| US-20070219298-A1 | Curable composition and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070212557-A1 | Curable composition and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-09-13 | — | — | US | disclosed |
| EP-1826239-A1 | Curable composition and coated article | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-08-29 | — | — | EP | disclosed |
| EP-1826233-A1 | Curable composition and coated article | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-08-29 | — | — | EP | disclosed |
| US-7193026-B2 | Organosilicon compound-curing composition and silicone-base coating composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| US-7157146-B2 | Primer composition, coating method, and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-20060172136-A1 | Coated member | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2006-08-03 | — | — | US | disclosed |
| US-20040260048-A1 | Organosilicon compound - curing composition and silicone-base coating composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-12-23 | — | — | US | disclosed |
| US-20040071998-A1 | Primer composition, coating method, and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-04-15 | — | — | US | disclosed |
| EP-1408082-A2 | Primer composition, coating method, and coated article | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528965-B2 | Active energy curable resin composition, hard coat laminated film, and film for application to glass | MAT2B, MECP2, MNAT1 | SERPINE1 1557/4885NPC1 4681/4885RAB9A 4704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.